Corpus Intelligence IC Memo — BAPTIST HEALTH MEDICAL CENTER - HSC 2026-04-26 10:39 UTC
IC Memo — BAPTIST HEALTH MEDICAL CENTER - HSC
Investment Committee Memorandum | AR | 71 beds | Grade D | EBITDA uplift $1.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BAPTIST HEALTH MEDICAL CENTER - HSC

CCN 040076 | HOT SPRING, AR | 71 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BAPTIST HEALTH MEDICAL CENTER - HSC is a 71-bed under-performing / distressed in HOT SPRING, AR with $23.6M in net patient revenue and a -4.7% operating margin. The hospital serves a payer mix of 19.0% Medicare, 20.7% Medicaid, and 60.3% commercial.

Thesis: Turnaround. Our ML models identify $1.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.7% to 2.7% (+736bps).

Net Revenue HCRIS$23.6M
Current EBITDA COMPUTED$-1.1M
Operating Margin COMPUTED-4.7%
Occupancy HCRIS22.0%
Revenue / Bed COMPUTED$333K
Net-to-Gross HCRIS25.5%
Distress Probability ML59.0%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
38
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -4.7% places it above the state median. Among 38 size-comparable peers (36-142 beds), the median margin is -2.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (36-142), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BAPTIST HEALTH MEDICAL CENTER (Target)AR71$23.6M-4.7%
ARKANSAS HEART HOSPITALAR112$205.9M1.2%
NATIONAL PARK MEDICAL CENTERAR126$118.8M2.6%
BHMC-CONWAYAR108$94.7M-15.6%
ST. MARYS REGIONAL MEDICAL CENAR137$94.3M6.7%
SALINE MEMORIAL HOSPITALAR130$91.4M-8.0%
NORTH ARKANSAS REGIONAL MEDICAAR120$89.1M-13.9%
SILOAM SPRINGS MEMORIAL HOSPITAR64$85.0M8.4%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$496K+210bp18mo
Cost to Collect4.5%2.5%$473K+200bp12mo
Denial Rate Reduction12.0%6.5%$468K+198bp12mo
A/R Days Reduction5200.0%3800.0%$287K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$496K
Cost to Collect
$473K
Denial Rate Reduction
$468K
A/R Days Reduction
$287K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.7M
Current EBITDA$-1.1M
+ RCM Uplift+$1.7M
Pro Forma EBITDA$630K
Current Margin-4.7%
Pro Forma Margin2.7%
WC Released (1x)$906K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.7M$10.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.7M$10.5M0.00x-100.0%
Bull Case9.0x11.0x$-1.5M$15.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.5M$16.7M0.00x-100.0%
Bear Case11.0x10.0x$-1.9M$1.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.9M$1.5M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 22.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 59.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 36-142 beds
  • Same-state prioritization (n=39)
  • Comp margins: P25=-16.9% / P50=-2.0% / P75=8.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.